The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Bonasol Once Weekly 70 mg Oral Solution

Xeolas Pharmaceuticals LimitedPA1572/001/001

Main Information

Trade NameBonasol Once Weekly 70 mg Oral Solution
Active SubstancesAlendronic acid
Dosage FormOral solution
Licence HolderXeolas Pharmaceuticals Limited
Licence NumberPA1572/001/001

Group Information

ATC CodeM05BA Bisphosphonates
M05BA04 alendronic acid


License statusAuthorised
Licence Issued25/02/2011
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportPDF Version
« Back